On the other hand, the overexpression of this molecule has been reported in many cancers, although its clinical meaning is still controversial (140–142), which could be, in part, due to the localization of ANXA1 in the nuclear and cytoplasmic compartments, and also associated to the membrane (131). This evidence concerns the gene ANXA1 and cancer.